missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. Novus Biologicals™ ST7/LRP12 Antibody (4E11C5), Novus Biologicals™
  7. 30033085

Novus Biologicals™ ST7/LRP12 Antibody (4E11C5), Novus Biologicals™

Mouse Monoclonal Antibody

Brand:  Novus Biologicals™ NBP3-27133-0.1ml

 View more versions of this product

Product Code. 30033085

  • 511.00€ / 0.10mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

ST7/LRP12 Monoclonal antibody specifically detects ST7/LRP12 in Human samples. It is validated for Flow Cytometry,ELISA,Western Blot
TRUSTED_SUSTAINABILITY
Specifications

Specifications

ST7/LRP12
Monoclonal
1 mg/mL
Western Blot 1:500 - 1:2000, Flow Cytometry 1:200 - 1:400, ELISA 1:10000
DKFZp762O2113, Protein FAM4A1, Protein HELG, SEN4, subfamily A, member 1, suppression of tumorigenicity 7, suppression of tumorigenicity 7 (breast), suppressor of tumorigenicity 7 protein
Purified recombinant fragment of human ST7/LRP12 (AA: extra 355-492) expressed in E. Coli.
0.1 mL
Primary
Human
Purified
Flow Cytometry, ELISA, Western Blot
4E11C5
Unconjugated
PBS
Mouse
Protein G purified
RUO
29967
Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
IgG2b
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.